First Phase III trial of an alpha-pharmaceutical shows improved survival in patients with bone metastases and advanced prostate cancer
September 22, 2011 by admin · Leave a Comment
Stockholm, Sweden: Until recently, options for patients with bone metastases from advanced prostate cancer have been very limited. But now the first Phase III study of an alpha-pharmaceutical in these patients has shown that it can prolong survival significantly, according to research reported today (Saturday) at the 2011 European Multidisciplinary Cancer Congress [1].
Queen’s pioneers prostate cancer breakthrough
September 18, 2011 by admin · Leave a Comment
Scientists at Queen’s University have pioneered a new combination treatment for prostate cancer. The treatment, which has been successful in phase one of trials, will now be tested for efficacy in a second phase.
UCSB develops breakthrough technology in identification of prostate cancer cells
September 18, 2011 by admin · Leave a Comment
A team of researchers at UC Santa Barbara has developed a breakthrough technology that can be used to discriminate cancerous prostate cells in bodily fluids from those that are healthy. The findings are published this week in the Proceedings of the National Academy of Sciences.
New prostate cancer screening test shows promise for diagnosis
August 14, 2011 by admin · Leave a Comment
Novel assay found to be more accurate than traditional screening
CLEVELAND - A new prostate screening test developed by AnalizaDx, Inc., a Cleveland-based biotech company, and studied by researchers at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center along with colleagues at the Cleveland Clinic, the Veterans Administration Boston Healthcare and the National Cancer Institute, may prove to be a promising new tool in the diagnosis of prostate cancer. The study which will be published in the September issue of Urology found that this new screening test, the PSA/SIA assay, may be more sensitive in detecting prostate cancer than traditional screening methods.
New treatment option for advanced prostate cancer
August 11, 2011 by admin · Leave a Comment
A successful interdisciplinary project is underway between two research groups, in which senior researcher Rebecka Hellsten and Professor Anders Bjartell at the Faculty of Medicine’s division for Urological Cancer Research, Skåne University Hospital in Malmö, and Professor Olov Sterner and Assistant Professor Martin Johansson at the Lund University division of Organic Chemistry recently published their latest research findings in the scientific online journal PLoS ONE.
ASCO: Experimental vaccine made from frozen immune cells shows promise for prostate cancer patients
June 1, 2011 by admin · Leave a Comment
Metastatic prostate cancer patients who received an investigational vaccine made from their own frozen immune cells lived 10 months longer than those not treated with it, according to data being presented by researchers from the Kimmel Cancer Center at Jefferson at the 2011 American Society of Clinical Oncology annual meeting in Chicago on Saturday, June 4. (ABSTRACT #4534)
New drug treatment extends lives of men with prostate cancer
May 24, 2011 by admin · Leave a Comment
AURORA, Colo. (May 25, 2011) - A drug recently approved by the Food & Drug Administration for the treatment of prostate cancer is proving to give some patients the gift of time. A new study shows abiraterone acetate extends the lives of men with the most advanced form of the disease by about four months. The study in the May 26, 2011 issue of the New England Journal of Medicine was co-authored by Thomas W. Flaig, MD, medical oncologist at the University of Colorado Hospital’s Tony Grampsas Urologic Oncology Clinic and assistant professor at the University of Colorado School of Medicine.
Mushroom compound suppresses prostate tumors
May 21, 2011 by admin · Leave a Comment
A mushroom used in Asia for its medicinal benefits has been found to be 100 per cent effective in suppressing prostate tumour development in mice during early trials, new Queensland University of Technology (QUT) research shows.
New prostate cancer test more specific, sensitive than PSA test
May 15, 2011 by admin · Leave a Comment
A new test for prostate cancer that measures levels of prostate specific antigen (PSA) as well as six specific antibodies found in the blood of men with the disease was more sensitive and more specific than the conventional PSA test used today, according to a study by researchers at UCLA’s Jonsson Comprehensive Cancer Center.
Microbubble-delivered combination therapy eradicates prostate cancer in vivo
May 9, 2011 by admin · Leave a Comment
